Laura Frosio
Research Subjects
Research Interests
Laura Frosio has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Alessandro Rossini
Endocrinology and Diabetes Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
1 shared publication- Antonella del Vecchio
Medical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy
1 shared publication - Francesca Perticone
Institute of Endocrine and Metabolic Sciences, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy
1 shared publication - Giorgio Spatola
Fondazione Poliambulanza Istituto Ospedaliero, Department of Neurosurgery, Brescia, Italy
1 shared publication Marco Losa
Department of Neurosurgery and Stereotactic Radiosurgery, Division of Neuroscience, IRCCS Ospedale San Raffaele, 20132 Milan, Italy; Department of Endocrinology, IRCCS Ospedale San Raffaele, 20132 Milan, Italy
1 shared publicationMarco Schiavo Lena
Department of Pathology, San Raffaele Hospital, Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 25 November 2019
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2019 (1)
Somatostatin analog challenge test in the pre-surgical management of ACTH-secreting pheochromocytoma
Summary: ACTH-secreting pheochromocytoma is a very rare cause of Cushing’s syndrome, with a high morbidity and mortality risk due to both cortisol and catecholamines excess. We report the case of a 45-year-old female patient with a 3 cm, high-density, left adrenal mass, diagnosed as an ACTH-secreting pheochromocytoma. The biochemical sensitivity of the tumor to somatostatin analogues was tested by a 100 μg s.c. octreotide administration, which led to an ACTH and cortisol reduction of 50 and 25% respectively. In addition to alpha and beta blockers, preoperative approach to laparoscopic adrenalectomy included octreotide, a somatostatin analogue, together with ketoconazole, in order to achieve an adequate pre-surgical control of cortisol release. Histopathological assessment confirmed an ACTH-secreting pheochromocytoma expressing type 2 and 5 somatostatin receptors (SSTR-2 and -5). Learning points: ACTH-secreting pheochromocytomas represent a rare and severe condition, characterized by high morbidity and mortality risk. Surgical removal of the adrenal mass is the gold standard treatment, but adequate medical therapy is required preoperatively to improve the surgical outcome and to avoid major complications. Somatostatin analogs, in addition to other medications, may represent a useful therapeutic option for the presurgical management of selected patients. In this sense, the octreotide challenge test is a useful tool to predict favorable therapeutic response to the treatment.
- 25 November 2019
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2019 (1)
Open AccessSomatostatin analog challenge test in the pre-surgical management of ACTH-secreting pheochromocytoma
Summary: ACTH-secreting pheochromocytoma is a very rare cause of Cushing’s syndrome, with a high morbidity and mortality risk due to both cortisol and catecholamines excess. We report the case of a 45-year-old female patient with a 3 cm, high-density, left adrenal mass, diagnosed as an ACTH-secreting pheochromocytoma. The biochemical sensitivity of the tumor to somatostatin analogues was tested by a 100 μg s.c. octreotide administration, which led to an ACTH and cortisol reduction of 50 and 25% respectively. In addition to alpha and beta blockers, preoperative approach to laparoscopic adrenalectomy included octreotide, a somatostatin analogue, together with ketoconazole, in order to achieve an adequate pre-surgical control of cortisol release. Histopathological assessment confirmed an ACTH-secreting pheochromocytoma expressing type 2 and 5 somatostatin receptors (SSTR-2 and -5). Learning points: ACTH-secreting pheochromocytomas represent a rare and severe condition, characterized by high morbidity and mortality risk. Surgical removal of the adrenal mass is the gold standard treatment, but adequate medical therapy is required preoperatively to improve the surgical outcome and to avoid major complications. Somatostatin analogs, in addition to other medications, may represent a useful therapeutic option for the presurgical management of selected patients. In this sense, the octreotide challenge test is a useful tool to predict favorable therapeutic response to the treatment.
- 1 November 2016
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 21 (6) , 555-559
Asymptomatic internal carotid artery occlusion after gamma knife radiosurgery for pituitary adenoma: Report of two cases and review of the literature
Gamma knife radiosurgery is an effective and safe treatment modality in the management of pituitary adenomas. Internal carotid occlusion is a rare but possible complication of Gamma Knife Radiosurgery for lesions within the cavernous sinus. To stress the importance of considering the Internal carotid artery as an organ at risk in cavernous sinus invading adenomas and reduce the dose delivered to this structure whenever possible. We report two cases of asymptomatic occlusion of the intracavernous segment of the internal carotid artery seven years after treatment in acromegalic patients. After trans-sphenoidal surgery, residual tumour was treated with gamma knife radiosurgery. The maximal doses to the affected artery were higher than 40 Gy and the 90% isodose was close to the arterial wall. Every effort should be done to minimize the radiation dose to the internal carotid artery. If not possible, "hot spots" exceeding the 90% isodose close to this vessel should be avoided.
- 1 November 2016
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 21 (6) , 555-559
Asymptomatic internal carotid artery occlusion after gamma knife radiosurgery for pituitary adenoma: Report of two cases and review of the literature
Gamma knife radiosurgery is an effective and safe treatment modality in the management of pituitary adenomas. Internal carotid occlusion is a rare but possible complication of Gamma Knife Radiosurgery for lesions within the cavernous sinus. To stress the importance of considering the Internal carotid artery as an organ at risk in cavernous sinus invading adenomas and reduce the dose delivered to this structure whenever possible. We report two cases of asymptomatic occlusion of the intracavernous segment of the internal carotid artery seven years after treatment in acromegalic patients. After trans-sphenoidal surgery, residual tumour was treated with gamma knife radiosurgery. The maximal doses to the affected artery were higher than 40 Gy and the 90% isodose was close to the arterial wall. Every effort should be done to minimize the radiation dose to the internal carotid artery. If not possible, "hot spots" exceeding the 90% isodose close to this vessel should be avoided.